Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

INVO Bioscience Q4 Sales $1.38M Up From $278.14K YoY

Author: Benzinga Newsdesk | April 16, 2024 05:02pm
INVO Bioscience (NASDAQ:INVO) reported $1.38 million in sales this quarter. This is a 396.15 percent increase over sales of $278.14 thousand the same period last year.

Posted In: INVO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist